Immune-developmental processes contribute to schizophrenia risk: insights from a genetic overlap study with height

Competing Interest Statement

C.d.L is funded by Hoffman-La Roche. The other authors declare no competing interests.

Funding Statement

C.R., B.A.P.C.M., M.P.vd.H., M.S., R.M.B., A.B.S., D.P. and S.v.d.S were funded by NWO Gravitation: BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology (grant no. 024.004.012 [to D.P.]). F.K. was supported by the Simons Foundation, SFARI Award 882976. D.P. and C.d.L. were funded by a European Research Council advanced grant (no. ERC-2018-AdG GWAS2FUNC 834057 [to D.P.]). M.P.v.d.H. is supported by NWO VIDI Grant 452-16-015 and the ERC Consolidator of the European Research Council Grant 101001062. The analyses were carried out on the Genetic Cluster Computer, which is financed by the Netherlands Scientific Organization (NWO: 480-05-003), by the VU University, Amsterdam, the Netherlands, and by the Dutch Brain Foundation, and is hosted by the Dutch National Computing and Networking Services SurfSARA. This research has been conducted using the UK Biobank resource under application number 16406. We thank the numerous participants, researchers, and staff from many studies who collected and contributed to the data. We particularly express our gratitude to all UKB participants that have been so generous to share their data for analysis.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes